Advancing Safe Medications for Moms and Babies Act of 2023

Bill 118 hr 1117, also known as the Advancing Safe Medications for Moms and Babies Act of 2023, aims to improve the safety of medications for pregnant women and infants. The bill focuses on enhancing research, education, and communication related to the use of medications during pregnancy and breastfeeding.

One key aspect of the bill is the establishment of a task force to review and update existing guidelines for the use of medications in pregnant and breastfeeding women. This task force will be composed of experts in the fields of obstetrics, pediatrics, pharmacology, and public health, among others. The goal of the task force is to ensure that healthcare providers have access to the most up-to-date information on the safety and efficacy of medications for pregnant and breastfeeding women.

Additionally, the bill includes provisions for increasing funding for research on the effects of medications on pregnant women and infants. This research will help to fill gaps in knowledge and provide healthcare providers with better information to guide their treatment decisions. The bill also emphasizes the importance of education and communication in ensuring the safe use of medications during pregnancy and breastfeeding. It calls for the development of educational materials for healthcare providers and patients, as well as the establishment of a public awareness campaign to raise awareness about the risks and benefits of medication use during pregnancy and breastfeeding. Overall, the Advancing Safe Medications for Moms and Babies Act of 2023 seeks to improve the safety and efficacy of medications for pregnant women and infants through enhanced research, education, and communication efforts.